Literature DB >> 34921674

Hyperglycemic memory in diabetic cardiomyopathy.

Jiabing Zhan1,2, Chen Chen1,2, Dao Wen Wang3,4, Huaping Li5,6.   

Abstract

Cardiovascular diseases account for approximately 80% of deaths among individuals with diabetes mellitus, with diabetic cardiomyopathy as the major diabetic cardiovascular complication. Hyperglycemia is a symptom that abnormally activates multiple downstream pathways and contributes to cardiac hypertrophy, fibrosis, apoptosis, and other pathophysiological changes. Although glycemic control has long been at the center of diabetes therapy, multicenter randomized clinical studies have revealed that intensive glycemic control fails to reduce heart failure-associated hospitalization and mortality in patients with diabetes. This finding indicates that hyperglycemic stress persists in the cardiovascular system of patients with diabetes even if blood glucose level is tightly controlled to the normal level. This process is now referred to as hyperglycemic memory (HGM) phenomenon. We briefly reviewed herein the current advances that have been achieved in research on the underlying mechanisms of HGM in diabetic cardiomyopathy.
© 2021. The Author(s).

Entities:  

Keywords:  diabetes; diabetic cardiomyopathy; hyperglycemic memory

Mesh:

Year:  2021        PMID: 34921674     DOI: 10.1007/s11684-021-0881-2

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  119 in total

Review 1.  Epidemic obesity and the metabolic syndrome.

Authors:  Steven Haffner; Heinrich Taegtmeyer
Journal:  Circulation       Date:  2003-09-30       Impact factor: 29.690

Review 2.  Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets.

Authors:  Hana Farhangkhoee; Zia A Khan; Harkiran Kaur; Xiping Xin; Shali Chen; Subrata Chakrabarti
Journal:  Pharmacol Ther       Date:  2005-12-15       Impact factor: 12.310

3.  Diabetic cardiomyopathy.

Authors:  R I Hamby; S Zoneraich; L Sherman
Journal:  JAMA       Date:  1974-09-23       Impact factor: 56.272

Review 4.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

Review 5.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Zhi You Fang; Johannes B Prins; Thomas H Marwick
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

Review 6.  Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?

Authors:  S Cosson; J P Kevorkian
Journal:  Diabetes Metab       Date:  2003-11       Impact factor: 6.041

Review 7.  Recipes for creating animal models of diabetic cardiovascular disease.

Authors:  Willa Hsueh; E Dale Abel; Jan L Breslow; Nobuyo Maeda; Richard C Davis; Edward A Fisher; Hayes Dansky; Donald A McClain; Richard McIndoe; Momtaz K Wassef; Cristina Rabadán-Diehl; Ira J Goldberg
Journal:  Circ Res       Date:  2007-05-25       Impact factor: 17.367

Review 8.  Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.

Authors:  Ashish Aneja; W H Wilson Tang; Sameer Bansilal; Mario J Garcia; Michael E Farkouh
Journal:  Am J Med       Date:  2008-09       Impact factor: 4.965

Review 9.  Diabetic cardiomyopathy: pathophysiology and clinical features.

Authors:  Takayuki Miki; Satoshi Yuda; Hidemichi Kouzu; Tetsuji Miura
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 10.  Application of Animal Models in Diabetic Cardiomyopathy.

Authors:  Wang-Soo Lee; Jaetaek Kim
Journal:  Diabetes Metab J       Date:  2021-03-25       Impact factor: 5.376

View more
  3 in total

1.  Cell-Target-Specific Anti-Inflammatory Effect of Empagliflozin: In Vitro Evidence in Human Cardiomyocytes.

Authors:  Silvia Giannattasio; Anna Citarella; Sofia Trocchianesi; Tiziana Filardi; Susanna Morano; Andrea Lenzi; Elisabetta Ferretti; Clara Crescioli
Journal:  Front Mol Biosci       Date:  2022-05-31

Review 2.  Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids.

Authors:  Ronghui Han; Hemeng Huang; Weiyi Xia; Jingjin Liu; Hui Luo; Jing Tang; Zhengyuan Xia
Journal:  Front Cardiovasc Med       Date:  2022-08-11

Review 3.  Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.

Authors:  Misganaw Asmamaw Mengstie; Endeshaw Chekol Abebe; Awgichew Behaile Teklemariam; Anemut Tilahun Mulu; Melaku Mekonnen Agidew; Muluken Teshome Azezew; Edgeit Abebe Zewde; Assefa Agegnehu Teshome
Journal:  Front Mol Biosci       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.